Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns up above $3.11
Key levels
Resistance$3.50
Resistance$3.29
Support$2.95
Support$2.70
Latest news & SEC filings
EarningsApyx Medical posts results for its 2026 third quarter
EarningsApyx Medical posts smaller quarterly loss than expected, revenue tops forecast
All APYX news →Apyx Medical is a surgical aesthetics company that develops and sells energy-based medical devices. Its main products include the Renuvion and AYON systems for cosmetic surgery and J-Plasma for hospital surgical use, all built on its helium plasma technology. The company also supplies generators and accessories to other device makers through OEM agreements. It operates in the United States and international markets, selling to plastic surgeons, cosmetic physicians, and hospitals through a direct sales force and distributors.
Based on the company's 10-K filed Mar 10, 2026.
Nasdaq · Healthcare
SEPT Low Target
$7.00
SEPT Mid Target
$7.00
SEPT High Target
$7.00
Analyst Consensus
$7.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for APYX.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$7.00
30
Moat Score
NONE
5/9
Piotroski Score
0.7
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Vizirgianakis Stavros G. | director | Buy | 450,000 | - | Jun 11, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
9.9%
3yr Revenue CAGR
5.9%
EPS Growth YoY
N/A
FCF Growth YoY
51.4%
Revenue Trend
STABLE
SEPT Investing tracks real-time dark pool institutional trades for APYX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:28:28 | $2.95 | 1,365 | $$4K | MIDPOINT |
| 18:32:28 | $2.97 | 1,000 | $$3K | BUY |
| 14:49:22 | $3.04 | 1,100 | $$3K | MIDPOINT |
| 18:46:24 | $2.90 | 2,000 | $$6K | SELL |
| 18:43:58 | $2.93 | 1,000 | $$3K | BUY |
5 dark pool trades shown · $$19K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Apyx Medical Corp (APYX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Apyx Medical Corp (APYX) is at $3.00, up 2.39% (+$0.07) at the Nov 11, 2026 close.
Latest APYX news — Nov 5, 2026: Apyx Medical posts results for its 2026 third quarter · Nov 5, 2026: Apyx Medical posts smaller quarterly loss than expected, revenue tops forecast
The average analyst price target for APYX is $7.00, ranging from $7 to $7, based on 1 analysts. Latest: HC Wainwright & Co. initiates on Jul 13, 2026.
Analyst ratings for APYX: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
APYX last reported on Aug 6, 2026: EPS -$0.07 vs -$0.08 expected — a beat of 14.6%.
APYX does not currently pay a dividend.
Apyx Medical Corp reported $38M of debt and $28M of cash (Jun 30, 2026).
Support: $2.95, $2.70, $2.32. Resistance: $3.29, $3.50, $3.75.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 5, 2026: Apyx Medical posts results for its 2026 third quarter · Nov 5, 2026: Apyx Medical posts smaller quarterly loss than expected, revenue tops forecast